"10.1371_journal.pone.0114991","plos one","2015-02-23T00:00:00Z","Cornelia Egger; Christian Lupinek; Robin Ristl; Patrick Lemell; Friedrich Horak; Petra Zieglmayer; Susanne Spitzauer; Rudolf Valenta; Verena Niederberger","Division of Immunopathology, Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria; Section for Medical Statistics, Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Vienna, Austria; Department Vienna Challenge Chamber, Allergy Centre Vienna West, Vienna, Austria; Department of Medical and Chemical Laboratory Diagnostics, Medical University of Vienna, Vienna, Austria; Department of Otolaryngology, Vienna General Hospital, Medical University of Vienna, Vienna, Austria","Conceived and designed the experiments: CE FH SS RV VN PL PZ. Performed the experiments: CE CL FH RV VN PL PZ. Analyzed the data: CE CL FH SS RV VN RR PL PZ. Contributed reagents/materials/analysis tools: CL FH SS RV RR. Wrote the paper: CE CL FH SS RV VN RR.","This study was supported by the Christian Doppler Research Association, Vienna, Austria, and by the following research grants from commercial funders: Biomay, Vienna, Austria, and Thermofisher/Phadia, Uppsala, Sweden. Trial Medication was provided by GlaxoSmithKline. Friedrich Horak has received funding from GSK and collaborated with them on a conduct clinical trial: \"A Randomized, Double-blind, Placebo Controlled, Incomplete Block, 3 Way Cross Over Study in Subjects With Allergic Rhinitis to Assess the Effect of Intranasal Repeat Doses of SB-705498 When Administered Alone or in Conjunction With Intranasal Fluticasone Propionate on the Symptoms of Rhinitis in the Vienna Allergen Challenge Chamber.\" Verena Niederberger has received research grants from the Austrian Science Fund (FWF), Allergy Therapeutics, UK, and Biomay, Vienna, Austria, has received honoraria for speaking at meetings from Thermofisher and has consulted Biomay, Vienna, Austria. Christian Lupinek has received honoraria from Thermofisher. Friedrich Horak has received research grants from Allergy Therapeutics, Calistoga, GSK, Meiji Seika, MSD, Oxagen, Schering Plough, and Stallergenes. Rudolf Valenta has received research grants from the Austrian Science Fund (FWF), from Biomay AG, Vienna, and Thermofisher, Uppsala, Sweden. He serves as a consultant for Biomay AG, Vienna, Austria, and Thermofisher, Uppsala, Sweden. All other authors have no conflicts of interest to declare. There are no further patents, products in development, or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2015","02","Cornelia Egger","CE",9,TRUE,7,7,9,7,TRUE,TRUE,FALSE,0,NA,FALSE
